Cannabidiol (Epidyolex®) accepted for use within NHS Scotland for Dravet syndrome

Cannabidiol oral solution is approved for use as adjunctive therapy of seizures associated with Dravet syndrome, in conjunction with clobazam, for patients 2 years of age and older.

Source:

Scottish Medicines Consortium